Market Access: Pharma

Mock Negotiations and Payer Consultations

Full-service solutions tailored to your needs

Alira Health provides a range of mock negotiation and payer consultation solutions to deliver commercial success, including:
  • Generation of integrated payer evidence and analyses plans to support market access and P&R
  • Preparation and facilitation of international payer-expert advisory boards to optimize development programs and gather insights on product value and evidence requirements
  • Design and facilitation of product value workshops with cross-functional and international teams
  • Payer/Health Technology Assessment (HTA) landscape assessments

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Access to a diverse

    integrated team with deep industry expertise

  • Close collaboration

    with our regulatory and clinical

  • Specific, local insights

    as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Jean-François Ricci
Jean-François Ricci
Executive Vice President, Global Market Access
Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle.

Related News

M&A MedTech Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Pharma
Events December 23, 2021
Event: Presentation of the 2021 BioRegion Report
We are thrilled to announce that Alira Health has contributed to the BioRegion Report 2021,
Clinical Pharma
Publications December 21, 2021
An Insider Look at Vaccines: Yesterday, Today, Tomorrow
The COVID-19 pandemic has put vaccines in the spotlight. The pandemic has given the industry a considerable boost, and with lessons learned during the development and roll-out(...)
Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Pharma
Events November 21, 2021
Webinar: RWE in Pharma: An Expert Panel Discussion
Join Catia Proenca, PhD, for a webinar on RWE in Pharma.
Clinical Digital Health MedTech Pharma
News November 16, 2021
Alira Health Further Expands its Digital Healthcare Platform with the Acquisition of Patchai
We acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research(...)
Pharma
Events November 1, 2021
Event: World Orphan Drug Congress Europe 2021
Join us at the World Orphan Drug Congress on November 15-18.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.